SynthesisFrontiers in oncology2025

Comparison of the efficacy based on clinicopathological characteristics and the safety of first-line treatments for patients with advanced ALK rearrangement non-small cell lung cancer: a network meta-analysis.

Yanwei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.